XML 58 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statement of Cash Flows (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jul. 01, 2012
Jul. 03, 2011
Cash flows from operating activities:    
NET INCOME (LOSS) $ (41,268) $ 12,354
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 101,495 67,186
Amortization of deferred financing cost 1,872  
Provision for doubtful accounts (186) 219
Settlement of foreign currency forward (3,701)  
Loss (gain) on disposition or impairment of assets 1,845 (113)
Deferred income taxes (9,145) (5,132)
Charge for stock based compensation 27,026 21,165
Credit facility issuance and refinancing costs 32,275 14,218
Change in assets and liabilities (net of acquisitions):    
Accounts receivable (24,635) 20,782
Inventories 16,423 9,283
Other current assets 30,196 (10,720)
Other assets 7,643 10,162
Accounts payable and accrued liabilities (43,846) (40,686)
Other long-term liabilities 19,997 (11,706)
Net cash provided by operating activities 115,991 87,012
Cash flows from investing activities:    
Purchases of property and equipment (39,750) (19,367)
Proceeds from the disposition of assets 325 2,157
Proceeds from the sale of investment 4,352  
Settlement of foreign currency forward 3,701  
Payments for acquisitions, net of cash acquired (584,218) (411,038)
Net cash used in investing activities (615,590) (428,248)
Cash flows from financing activities:    
Repayments of credit facility (55,625) (51,876)
Credit facility issuance costs and refinancing costs (41,790) (14,218)
Proceeds from credit facility 959,708 425,000
Extinguishment of debt (470,296)  
Net proceeds from stock awards 8,024 28,626
Net cash provided by financing activities 400,021 387,532
Net increase (decrease) in cash and cash equivalents (99,578) 46,296
Cash and cash equivalents at beginning of period 266,631 199,950
Cash and cash equivalents at end of period $ 167,053 $ 246,246